A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18.
Mononuclear blood cells from a multiparous woman were transformed with Epstein Barr virus, and a cell line (Tr2D8) producing anti-HLA antibody was obtained. This cell line was immortalized by hybridization to the human fusion partners KR4 and KR12. While the EBV line died after 7 months, the hybridomas have remained stable for 13 months. The EBV line supernatant (40 micrograms IgM/ml) lysed peripheral blood mononuclear cells (PBMC) bearing B15, B17, B5 and B35. Consistent lysis of B18 bearing cells was only observed with lymphoblastoid cell lines. The supernatant from the Tr2D8 (EBV line X KR4) hybridoma (2.7 micrograms IgM/ml) only lysed B15 bearing PBMC. At a concentration of 13.5 micrograms IgM/ml, the hybridoma antibody lysed lymphoblastoid cell lines bearing B15, B17, B5, B35 and B18.
Hansen
T
T
Institute of Medical Biology, School of Medicine, University of Tromsø, Norway.
Kolstad
A
A
Thorsby
E
E
Hannestad
K
K
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D002460:Cell Line; D002472:Cell Transformation, Viral; D003429:Cross Reactions; D006680:HLA Antigens / Q000276:immunology*; D015235:HLA-B Antigens; D059910:HLA-B15 Antigen; D004854:Herpesvirus 4, Human; D006801:Humans; D006825:Hybridomas / Q000276:immunology*
D000911:Antibodies, Monoclonal; D006680:HLA Antigens; D015235:HLA-B Antigens; D059910:HLA-B15 Antigen